Radvanyi
Etienne Radvanyi, Grenoble FR
Patent application number | Description | Published |
---|---|---|
20140295281 | Lithiated Manganese Phosphate and Composite Material Comprising Same - The invention relates to a lithiated manganese phosphate and to a composite material comprising same. The lithiated manganese phosphate of the invention has formula I: Li | 10-02-2014 |
Francois Radvanyi, Fontenay Aux Roses FR
Patent application number | Description | Published |
---|---|---|
20100166737 | P38Alpha as a Therapeutic Target in Bladder Carcinoma - The present invention concerns methods and compositions for treating bladder carcinoma by p38 inhibitors. | 07-01-2010 |
20120034167 | TYROSINE KINASE RECEPTOR TYRO3 AS A THERAPEUTIC TARGET IN THE TREATMENT OF CANCER - The present invention concerns new methods for treating cancer by using TYRO3 inhibitors and methods for identifying new molecules of interest for treating cancer. | 02-09-2012 |
20120282167 | METHOD FOR PREDICTING THE SENSITIVITY OF A TUMOR TO AN EPIGENETIC TREATMENT - The present invention provides a method for determining the RES phenotype in a tumor. The present invention further provides a method for predicting the sensitivity of a tumor to an epigenetic treatment, the method comprising determining the RES phenotype in said tumor, the presence of the RES phenotype in a tumor being indicative of a tumor sensitive to an epigenetic therapy. The present invention also provides a method for diagnosing an aggressive tumor and for selecting a patient affected with a tumor for an epigenetic therapy. | 11-08-2012 |
20130059303 | CDKN2A AS A PROGNOSTIC MARKER IN BLADDER CANCER - The present invention provides methods for predicting clinical outcome and for providing information for determining follow-up strategy of a subject affected with a non-muscle invasive bladder cancer, as well as a method for selecting a subject affected with a non-muscle invasive bladder cancer for an anti-tumoral therapy. The present invention also provides kits for implementing these methods. | 03-07-2013 |
François Radvanyi, Paris FR
Patent application number | Description | Published |
---|---|---|
20140193927 | PREDICTION OF RECURRENCE FOR BLADDER CANCER BY A PROTEIN SIGNATURE IN TISSUE SAMPLES - The present invention pertains to the field of cancer prediction. Specifically, it relates to a method for predicting the risk of recurrence of bladder cancer in a subject after treatment of bladder cancer comprising the steps of determining the amount of at least one biomarker selected from the biomarkers shown in Table, and comparing the amount of said at least one biomarker with a reference amount for said at least one biomarker, whereby the risk of recurrence of bladder cancer is to be predicted. The present invention also contemplates a method for identifying a subject being in need of a further bladder cancer therapy. Encompassed are, furthermore, diagnostic devices and kits for carrying out said methods. | 07-10-2014 |
Gabor Radvanyi, Budapest HU
Patent application number | Description | Published |
---|---|---|
20140124472 | MOSAIC PIECE - Provided is a mosaic piece having a body contour inscribed within a circle, and being formed with at least one projection having a projection contour. | 05-08-2014 |
Laszio Radvanyi, Houston, TX US
Patent application number | Description | Published |
---|---|---|
20110311543 | Tumor Antigens BFA5 for Prevention and/or Treatment of Cancer - The present invention relates to a nucleic acid encoding a polypeptide and the use of the nucleic acid or polypeptide in preventing and/or treating cancer. In particular, the invention relates to improved vectors for the insertion and expression of foreign genes encoding tumor antigens for use in immunotherapeutic treatment of cancer. | 12-22-2011 |